Viewing Study NCT04866056


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-28 @ 8:29 PM
Study NCT ID: NCT04866056
Status: TERMINATED
Last Update Posted: 2022-12-01
First Post: 2021-04-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module